APA (7th ed.) Citation

Luo, J., Xiao, W., Hua, F., Cao, Y., Wang, D., & Wang, X. (2023, November). Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: A systematic review and meta-analysis. BMC Cancer.

Chicago Style (17th ed.) Citation

Luo, Jian, Wanying Xiao, Fengyang Hua, Yanqing Cao, Dongxia Wang, and Xicheng Wang. "Efficacy and Safety of PD-1 Inhibitors in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of Platinum-containing Regimens: A Systematic Review and Meta-analysis." BMC Cancer Nov. 2023.

MLA (9th ed.) Citation

Luo, Jian, et al. "Efficacy and Safety of PD-1 Inhibitors in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of Platinum-containing Regimens: A Systematic Review and Meta-analysis." BMC Cancer, Nov. 2023.